Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Parish

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Nano Letters|March 10, 2022
Spatially Controlled Activation of Toll-like Receptor 9 with DNA-Based NanomaterialsAlice Comberlato, Marianna M Koga, Simone Nüssing, et al.
Immunology and Cell Biology|June 15, 2017
Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulationDeborah L Burnett, Ian A Parish, Etienne Masle-Farquhar, et al.
The American Journal of Pathology|September 25, 2025
Retraction Notice to "Aberrant CD8<sup>+</sup> T-Cell Responses and Memory Differentiation upon Viral Infection of an Ataxia-Telangiectasia Mouse Model Driven by Hyper-Activated Akt and mTORC1 Signaling" [Am J Pathol 178 (2011) 2740-2751]Anthony D D'Souza, Ian A Parish, Sharen E McKay, et al.
The American Journal of Pathology|June 7, 2011
Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signalingAnthony D D'Souza, Ian A Parish, Sharen E McKay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2012
Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasiaAnthony D D'Souza, Ian A Parish, Diane S Krause, et al.
Cell Reports|July 19, 2018
The Ubiquitin Ligase Adaptor NDFIP1 Selectively Enforces a CD8<sup>+</sup> T Cell Tolerance Checkpoint to High-Dose AntigenMayura V Wagle, Julia M Marchingo, Jason Howitt, et al.
Blood|February 11, 2009
The molecular signature of CD8+ T cells undergoing deletional toleranceIan A Parish, Sudha Rao, Gordon K Smyth, et al.
Immunity|August 12, 2009
Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell propertiesRachel L Rutishauser, Gislâine A Martins, Sergey Kalachikov, et al.
ACS Nano|December 21, 2023
Balancing the Nanoscale Organization in Multivalent Materials for Functional Inhibition of the Programmed Death-1 Immune CheckpointKaltrina Paloja, Jorieke Weiden, Joschka Hellmeier, et al.
Cell Reports|January 19, 2022
Uncontrolled CD21<sup>low</sup> age-associated and B1 B cell accumulation caused by failure of an EGR2/3 tolerance checkpointEtienne Masle-Farquhar, Timothy J Peters, Lisa A Miosge, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Nano Letters|March 10, 2022
Spatially Controlled Activation of Toll-like Receptor 9 with DNA-Based NanomaterialsAlice Comberlato, Marianna M Koga, Simone Nüssing, et al.
Immunology and Cell Biology|June 15, 2017
Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulationDeborah L Burnett, Ian A Parish, Etienne Masle-Farquhar, et al.
The American Journal of Pathology|September 25, 2025
Retraction Notice to "Aberrant CD8<sup>+</sup> T-Cell Responses and Memory Differentiation upon Viral Infection of an Ataxia-Telangiectasia Mouse Model Driven by Hyper-Activated Akt and mTORC1 Signaling" [Am J Pathol 178 (2011) 2740-2751]Anthony D D'Souza, Ian A Parish, Sharen E McKay, et al.
The American Journal of Pathology|June 7, 2011
Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signalingAnthony D D'Souza, Ian A Parish, Sharen E McKay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2012
Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasiaAnthony D D'Souza, Ian A Parish, Diane S Krause, et al.
Cell Reports|July 19, 2018
The Ubiquitin Ligase Adaptor NDFIP1 Selectively Enforces a CD8<sup>+</sup> T Cell Tolerance Checkpoint to High-Dose AntigenMayura V Wagle, Julia M Marchingo, Jason Howitt, et al.
Blood|February 11, 2009
The molecular signature of CD8+ T cells undergoing deletional toleranceIan A Parish, Sudha Rao, Gordon K Smyth, et al.
Immunity|August 12, 2009
Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell propertiesRachel L Rutishauser, Gislâine A Martins, Sergey Kalachikov, et al.
ACS Nano|December 21, 2023
Balancing the Nanoscale Organization in Multivalent Materials for Functional Inhibition of the Programmed Death-1 Immune CheckpointKaltrina Paloja, Jorieke Weiden, Joschka Hellmeier, et al.
Cell Reports|January 19, 2022
Uncontrolled CD21<sup>low</sup> age-associated and B1 B cell accumulation caused by failure of an EGR2/3 tolerance checkpointEtienne Masle-Farquhar, Timothy J Peters, Lisa A Miosge, et al.
Pageof 6